<DOC>
	<DOCNO>NCT01458938</DOCNO>
	<brief_summary>The objective pilot study determine degenerative spinal disorder acute radiculopathy , myelopathy , stenosis , disc facet disease cause detectable alteration Substance P level saliva , serum cerebrospinal fluid . If pilot study show correlation Substance P level pain associate degenerative spinal disorder , large study initiate determine feasibility use Substance P level diagnosis treatment degenerative spinal disease .</brief_summary>
	<brief_title>This Study Determine Degenerative Spinal Pain Disorders Cause Levels Substance P Change Patients Saliva , Blood and/or Cerebrospinal Fluid .</brief_title>
	<detailed_description />
	<mesh_term>Radiculopathy</mesh_term>
	<mesh_term>Spinal Cord Diseases</mesh_term>
	<mesh_term>Spinal Diseases</mesh_term>
	<mesh_term>Substance P</mesh_term>
	<mesh_term>Neurokinin A</mesh_term>
	<criteria>Undergoing spinal surgery medically refractory spinal radiculopathy , myelopathy neurogenic claudication base either history , physical examination radiologic study demonstrate neural compression degenerative disc disease . Undergoing surgery medically refractory axial spinal pain . Previous spinal procedure operation , radicular pain , history fibromyalgia , chronic pain , rheumatoid arthritis , autoimmune disorder , HIV , PTSD , Major Depressive Disorder , migraine headache active rhinosinusitis , nicotine intake</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>